Bosutinib OverviewBosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer. Contents 1 Mechanism 2 Medical uses 3 Adverse effects 3.1 Contraindications 3.2 Interactions 3.3 Carcinogenicity and mutagenicity 4 Quality issues 5 Notes 6 See also 7 References 8 External links Mechanism It is an ATP-c...
Read more Bosutinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bosutinib
Recent Bosutinib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 100mg, 400mg, 500mg